-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Intellectual Property
Session Summary: What Every CEO Must Know About IP In Biotech
On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every CEO Must Know About IP In Biotech”, part of Day One of Entrepreneurship Boot Camp. Kathryn Doyle, Ph.D., J.D., of Riverside Law and Stephan Sammut of the Wharton School spoke about changing patent laws and what they mean for biotech companies. Concepts and tips discussed included: How to develop a patent strategy when developing a product you’re trying to commercialize When Read More >
Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished
The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of copyrighted books exhausted the copyright under the First Sale Doctrine. In a vain attempt at corporate responsibility, the publishers in this case created two versions of textbooks; a no-frills “Asia edition” to sell at affordable prices to students in less affluent places like Thailand, and a higher quality more expensive version to relatively more affluent students in places like the Read More >
BIO IPCC Conference Launches Next Week
BIO’s IPCC Spring Conference is in San Diego next week, March 25-27. Find this year’s line-up below and follow me on twitter at @rzwahlen for live tweeting of the panels. Pre-Conference Workshop: Effecting and Managing Change Sponsored by: Foley & Lardner LLP The panel will discuss lobbying and public messaging about IP. This workshop will provide an overview and illustrative anecdotes on how to lobby Congress and the administration on certain issues. and how to Read More >
BIO IP Counsels Committee Conference: Spring 2013 Line-Up
San Diego, California is the next site for the BIO IP Counsels Committee Conference. On March 25, 2013, biotech IP counsel will gather for an event dedicated to providing in-house IP counsel opportunities to learn cutting edge issues, network with their peers, and to enjoy another great location. Here is the session line-up and confirmed speakers with more speaker confirmations to come. Visit BIO’s IP Counsels Committee Conference page to register and learn more. Pre-Conference Read More >
My family farm isn’t under “corporate control”
On CNN’s blog, “Eatocracy”, Indiana farmer Brian Scott challenges the myth that farmers are slaves to “Big Ag” and explains from first-hand experience how biotech seed contracts work. In his blog post titled, “My family farm isn’t under ‘corporate control’“, Scott posts a copy of an actual technology agreement he signed, and explains how such agreements help him to operate the farm in the manner his family chooses. Among the requirements of technology and stewardship Read More >
